Navigating Risk and Seizing Opportunity in the New Health
The New Health Needs a New Kind of Ally
This Enterprise brochure reviews how the biopharma landscape has changed. It calls for greater efficiencies, faster outcomes, new sources of capital, smarter ways of assessing risk and global ways of executing. The New Health needs a new kind of ally. Quintiles is helping bio and pharmaceutical companies navigate the way.
